Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 9.78% Profit Margin

March 10, 2025
BRISTOL-MYERS SQUIBB COMPANY has reached the price target forecasted by QuantWave with a profitable outcome of 9.78%. The forecast signal, issued on December 10, 2024, indicated a long position with a price of $56.87. Today, on March 10, 2025, the stock has successfully surged to $62.43, aligning perfectly with the prediction.

This achievement showcases the accuracy and reliability of QuantWave's analytics in forecasting stock movements. In the volatile world of finance, where every cent matters, being able to foresee a nearly 10% increase in price can make a significant difference for investors. This success story underscores the potential value that QuantWave's forecasting platform can offer to market participants seeking to optimize their investment decisions.

The uptick in BRISTOL-MYERS SQUIBB COMPANY's stock can be attributed to several factors, including positive clinical trial results, successful product launches, and overall strong performance in the pharmaceutical sector. Additionally, a favorable market environment and investor sentiment towards healthcare stocks have also played a role in driving up the stock price.

QuantWave continues to provide invaluable insights and forecasts for a wide range of stocks, empowering users to capitalize on profitable opportunities in the market. For those interested in delving deeper into our investment strategy, QuantSchool offers a comprehensive educational framework designed to guide individuals in leveraging the QuantWave forecasting system effectively. By understanding the key principles outlined in QuantSchool, investors can enhance their ability to generate consistent income through informed decision-making based on QuantWave's predictive analytics.
If you want to leave a comment, then you need Login or Register





Other data for BMY

Related data

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success  ~2 min.

On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit  ~1 min.

On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit  ~1 min.

On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Target Forecast with 13.0% Profit - QuantWave Analysis  ~1 min.

On April 11, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.05....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 10.38% Profit: QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY, a renowned pharmaceutical company, recently achieved its price target forecast set by QuantWave's automated forecasting platform....

PFEJune 11, 2025PFIZER INC. Hits Price Target Forecast with 6.25% Profit, Validating QuantWave's Analytics  ~1 min.

PFIZER INC. has successfully reached the price target forecast set by QuantWave, signaling a profitable long position. The forecast signal was issued on 2025-05-21 when the stock was at 23.04 $....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....

GSKFebruary 5, 20259.43% Profit Achieved: GSK PLC Hits Price Target Forecast on QuantWave  ~1 min.

On December 11, 2024, QuantWave's automated forecasting platform issued a long signal for GSK PLC with a price of $33.69....

PFEDecember 14, 2022PFIZER INC. Hits Price Target Forecast with 9.65% Profit: A Success Story for QuantWave  ~1 min.

In a significant milestone for QuantWave, the automated forecasting platform successfully predicted a long signal for PFIZER INC. on August 12, 2022, when the stock was trading at 43.24 $....

GSKFebruary 5, 2024GSK PLC Hits Price Target Forecast with 10.82% Profit as Predicted by QuantWave  ~2 min.

On February 5, 2024, GSK PLC successfully reached the price target forecast set by QuantWave, resulting in a profit of 10.82% for investors who followed the prediction....